PARIS, FRANCE: Virbac, an animal health pharmaceutical company, has bought 34% of the shares of the Centrovet group, thus increasing its stake to 100%. The consideration paid for the acquisition of this stake is US $43.7 million, paid in full and in cash upon closing, to which will be added, if applicable, an additional consideration…